NervGen Pharma Corp. (NGEN.V)
6.02
+0.17
(+2.91%)
CAD |
TSXV |
Feb 20, 16:00
NervGen Pharma Total Assets (Quarterly) : 13.08M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arch Biopartners, Inc. | 0.1045M |
| Biocure Technology, Inc. | 2.018M |
| Resverlogix Corp. | 10.91M |
| Microbix Biosystems, Inc. | 36.59M |
| Theratechnologies, Inc. | 70.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.02M |
| Shareholders Equity (Quarterly) | -2.942M |
| Debt to Equity Ratio | -0.0113 |
| Current Ratio | 0.7899 |
| Net Debt Paydown Yield | 0.01% |